This brand name is authorized in Ecuador, Hong Kong, Singapore
The drug CANDITRAL contains one active pharmaceutical ingredient (API):
|
1
Itraconazole
UNII 304NUG5GF4 - ITRACONAZOLE
|
|
Itraconazole is a triazole derivative that inhibits fungal 14ฮฑ-demethylase, resulting in a depletion of ergosterol and disruption of membrane synthesis by fungi. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J02AC02 | Itraconazole | J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria | Identifier(s): 26.357-04-05 |
| Country: HK | Department of Health Drug Office | Identifier(s): 50434 |
| Country: SG | Health Sciences Authority | Identifier(s): 11355P |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
